Selective reduction of left ventricular ejection time (LVET) in hypertrophic cardiomyopathy patients carrying mutations in MYBPC3

Back

HFA Premium Access

Selective reduction of left ventricular ejection time (LVET) in hypertrophic cardiomyopathy patients carrying mutations in MYBPC3

Session: Myocardial disease - clinical 7

Topic: Hypertrophic Cardiomyopathy

Speaker: Professor M. Patten (Hamburg, DE)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Professor Monica Patten

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

0 follower

7 more presentations in this session

Identification of a novel actin gene mutation, ACTC1 p.Asn94Ile, in a family with cardiomyopathy and conduction disease

Speaker: Doctor R. Sepp (Szeged, HU)

Refining the diagnosis of hypertrophic cardiomyopathy with a machine learning-based radiomics model: a cardiovascular magnetic resonance study

Speaker: Doctor I. Miranda (Amadora, PT)

Different exercise hemodynamic profiles in obstructive and nonobstructive hypertrophic cardiomyopathy: importance of unmasking diastolic dysfunction

Speaker: Doctor C. Baratto (Milan, IT)

Cardiac magnetic resonance feature tracking identifies preclinical abnormalities in hypertrophic cardiomyopathy sarcomere gene mutation carriers

Speaker: Doctor F. Negri (Udine, IT)

Unraveling the complexity of hypertrophic cardiomyopathy: a machine learning-based radiomics model to predict phenotype and cardiovascular events

Speaker: Doctor I. Miranda (Amadora, PT)

Access the full session

Myocardial disease - clinical 7

Speakers: Professor M. Patten, Doctor R. Sepp, Doctor I. Miranda, Doctor C. Baratto, Doctor F. Negri...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources